PTGX

PROTAGONIST THERAPEUTICS INC

Healthcare | Mid Cap

$0.02

EPS Forecast

$49.84

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
MCRBSeres Therapeutics IncARVNArvinas IncCMRXChimerix IncRVNCRevance Therapeutics IncTGTXTg Therapeutics IncYMABY-mabs Therapeutics Inc